Keyphrases
Alzheimer's Disease
16%
Atrophy
16%
Axonal Degeneration
16%
Axonal Injury
16%
Brain Connectivity
16%
Cerebral Cortex
16%
Chaperone Function
16%
Cortical Neurons
16%
Detergent
16%
Drosophila Model
16%
Functional Connectivity
16%
Hippocampal Atrophy
16%
Hyperphosphorylation
16%
Inflammation
16%
Inflammatory Markers
16%
Insoluble tau
50%
Microtubule-associated Protein tau
16%
Mouse in Vivo
16%
Mouse Model
100%
Neonatal Hypoxia-ischemia
16%
Neurodegeneration
33%
Neuronal Function
100%
Neuroprotective
16%
Nicotinamide Adenine Dinucleotide (NAD+)
16%
Nicotinamide Mononucleotide Adenylyltransferase (NMNAT)
16%
NMNAT1
100%
Overexpression
50%
P301S Mice
50%
Pathologic
16%
Phospho-tau
100%
Potent Inhibitor
16%
Protective Effect
16%
Protein Chaperone
16%
Soluble Aggregates
16%
Tau Aggregates
16%
Tau Misfolding
16%
Tau Pathology
100%
Tau Phosphorylation
33%
Tauopathy
100%
Therapeutic Target
16%
τ-induced
16%
Medicine and Dentistry
Alzheimer's Disease
14%
Axonal Injury
14%
Cerebral Cortex
14%
Chaperone
14%
Disease
14%
Functional Connectivity
28%
Hyperphosphorylation
14%
Ischemia
14%
Nerve Fiber Degeneration
14%
Neurodegeneration
28%
Neuroprotective Agent
14%
Newborn Hypoxia
14%
Nicotinamide Nucleotide Adenylyltransferase
14%
Tau
100%
Tau Protein
14%
Tauopathy
100%
Neuroscience
Alzheimer's Disease
16%
Axonal Degeneration
16%
Cerebral Cortex
16%
Chaperone
16%
Functional Connectivity
33%
Hyperphosphorylation
16%
In Vivo
16%
Ischemia
16%
Nerve Fiber Degeneration
16%
Neurodegeneration
33%
Neuroprotective Agent
16%
Nicotinamide Nucleotide Adenylyltransferase
16%
Tau Protein
16%
Tauopathy
100%